Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

Brieana M. Rowles, Robert L. Findling

Research output: Contribution to journalReview articlepeer-review

Abstract

Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

Original languageEnglish (US)
Pages (from-to)273-282
Number of pages10
JournalDevelopmental Disabilities Research Reviews
Volume16
Issue number3
DOIs
StatePublished - 2010
Externally publishedYes

Keywords

  • Attention-deficit/hyperactivity disorder
  • Developmental disorder
  • Subaverage intelligence
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders'. Together they form a unique fingerprint.

Cite this